Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.
Saved in:
| Title: | Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols. |
|---|---|
| Authors: | Neumann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. m.neumann@uksh.de.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany. m.neumann@uksh.de.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany. m.neumann@uksh.de., Beder T; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Bastian L; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Hänzelmann S; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany., Bultmann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Wolgast N; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Hartmann A; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Trautmann H; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Ortiz-Tanchez J; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Schlee C; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Schroeder M; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Fransecky L; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Vosberg S; Department of Internal Medicine III, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Fiedler W; Medical Department II, Hematology and Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany., Alakel N; Medical Department I, Carl Gustav Carus University Hospital Dresden, Dresden, Germany., Heberling L; Medical Department I, Carl Gustav Carus University Hospital Dresden, Dresden, Germany., Kondakci M; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Starck M; Medical Department I, Hospital München-Schwabing, Schwabing, Germany., Schwartz S; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Raffel S; Medical Department V, University Hospital Heidelberg, Heidelberg, Germany., Müller-Tidow C; Medical Department V, University Hospital Heidelberg, Heidelberg, Germany., Schneller F; Medical Department III, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Reichle A; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany., Burmeister T; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany., Greif PA; Department of Internal Medicine III, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Brüggemann M; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany., Gökbuget N; Department of Medicine II, Hematology/Oncology, University Hospital, Goethe University, Frankfurt/M, Germany., Baldus CD; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany. |
| Source: | Leukemia [Leukemia] 2024 Jun; Vol. 38 (6), pp. 1213-1222. Date of Electronic Publication: 2024 May 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38744920 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Neumann+M%22">Neumann M</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany. m.neumann@uksh.de.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany. m.neumann@uksh.de.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany. m.neumann@uksh.de.<br /><searchLink fieldCode="AU" term="%22Beder+T%22">Beder T</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Bastian+L%22">Bastian L</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Hänzelmann+S%22">Hänzelmann S</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Bultmann+M%22">Bultmann M</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Wolgast+N%22">Wolgast N</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+A%22">Hartmann A</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Trautmann+H%22">Trautmann H</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Ortiz-Tanchez+J%22">Ortiz-Tanchez J</searchLink>; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schlee+C%22">Schlee C</searchLink>; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Schroeder+M%22">Schroeder M</searchLink>; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Fransecky+L%22">Fransecky L</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Vosberg+S%22">Vosberg S</searchLink>; Department of Internal Medicine III, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fiedler+W%22">Fiedler W</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Hamburg Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Alakel+N%22">Alakel N</searchLink>; Medical Department I, Carl Gustav Carus University Hospital Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Heberling+L%22">Heberling L</searchLink>; Medical Department I, Carl Gustav Carus University Hospital Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Kondakci+M%22">Kondakci M</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Starck+M%22">Starck M</searchLink>; Medical Department I, Hospital München-Schwabing, Schwabing, Germany.<br /><searchLink fieldCode="AU" term="%22Schwartz+S%22">Schwartz S</searchLink>; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Raffel+S%22">Raffel S</searchLink>; Medical Department V, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Tidow+C%22">Müller-Tidow C</searchLink>; Medical Department V, University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schneller+F%22">Schneller F</searchLink>; Medical Department III, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Reichle+A%22">Reichle A</searchLink>; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Burmeister+T%22">Burmeister T</searchLink>; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Greif+PA%22">Greif PA</searchLink>; Department of Internal Medicine III, University Hospital LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Brüggemann+M%22">Brüggemann M</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Gökbuget+N%22">Gökbuget N</searchLink>; Department of Medicine II, Hematology/Oncology, University Hospital, Goethe University, Frankfurt/M, Germany.<br /><searchLink fieldCode="AU" term="%22Baldus+CD%22">Baldus CD</searchLink>; Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010/1), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel and Lübeck, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2024 Jun; Vol. 38 (6), pp. 1213-1222. <i>Date of Electronic Publication: </i>2024 May 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38744920 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-024-02264-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1213 Titles: – TitleFull: Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Neumann M – PersonEntity: Name: NameFull: Beder T – PersonEntity: Name: NameFull: Bastian L – PersonEntity: Name: NameFull: Hänzelmann S – PersonEntity: Name: NameFull: Bultmann M – PersonEntity: Name: NameFull: Wolgast N – PersonEntity: Name: NameFull: Hartmann A – PersonEntity: Name: NameFull: Trautmann H – PersonEntity: Name: NameFull: Ortiz-Tanchez J – PersonEntity: Name: NameFull: Schlee C – PersonEntity: Name: NameFull: Schroeder M – PersonEntity: Name: NameFull: Fransecky L – PersonEntity: Name: NameFull: Vosberg S – PersonEntity: Name: NameFull: Fiedler W – PersonEntity: Name: NameFull: Alakel N – PersonEntity: Name: NameFull: Heberling L – PersonEntity: Name: NameFull: Kondakci M – PersonEntity: Name: NameFull: Starck M – PersonEntity: Name: NameFull: Schwartz S – PersonEntity: Name: NameFull: Raffel S – PersonEntity: Name: NameFull: Müller-Tidow C – PersonEntity: Name: NameFull: Schneller F – PersonEntity: Name: NameFull: Reichle A – PersonEntity: Name: NameFull: Burmeister T – PersonEntity: Name: NameFull: Greif PA – PersonEntity: Name: NameFull: Brüggemann M – PersonEntity: Name: NameFull: Gökbuget N – PersonEntity: Name: NameFull: Baldus CD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2024 Jun Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 38 – Type: issue Value: 6 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |